ArsenalBio
202 employees
Biotech/Pharma
Growth · $603.3M
Open positions (1)
Company details
Team Size202
IndustryBiotech/Pharma
Funding
Total raised
$603.3M
Last stage
Growth
Investors
Total raised
$603.3M
Last stage
Growth
Investors
Kole Roybal
Scientific co-founder; Assistant Professor of Immunology at UCSF and PICI Investigator; contributed synthetic biology and cell engineering expertise to ArsenalBio's founding platform.
Ken Drazan
MD; previously President & Chief Business Officer of GRAIL (acquired by Illumina); founder and Board Director of Verb Surgical (acquired by J&J); co-founded private equity firm Bertram Capital; board-certified liver transplant surgeon with prior faculty appointments at Stanford and UCLA.
LinkedInW. Nicholas Haining
Physician-scientist; formerly VP of Discovery Oncology and Immunology at Merck Research Laboratories; Associate Professor of Pediatrics at Harvard Medical School; Associate Member of the Broad Institute of Harvard and MIT.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.